Life Sciences Report Collection
![Loading Reports](/public/images/ajax-loader.gif)
The Life Sciences Collection spans markets that are central to the life and wellbeing of the more than 7.5 billion people on our planet. From emerging diagnostics, to brand new therapies and treatment technologies, our expert analysts know where your focus – and investment – should be when it comes to biotechnology, pharmaceuticals and healthcare. As your senior editor, I look forward to introducing you to new opportunities.
Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and...
The global single nucleotide polymorphism (SNP) genotyping market was valued at $3.5 billion in 2013. This market is expected to reach $4.3 billion in 2014 and $11.5 billion in 2019, a compound annual growth rate (CAGR) of 21.9% from 2014 to 2019.
Global Markets for Nanoparticle Size Analysis Instrumentation in ...
The global market for nanoparticles instrumentation in life sciences was $5.6 billion in 2013. This value is expected to increase to $5.9 billion in 2014 and about $7.8 billion by 2019, a compound annual growth rate (CAGR) of 5.7% for the five-year period, 2014 to 2019.
G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Glo...
The global G protein, coupled receptors (GPCR) targeting drug market sharply fell in the last three years due to a series of patent expirations of blockbuster products. The market receded from nearly $111 billion to almost $100 billion with a -3.4% compound annual growth rate (CAGR) between 2010 and 2013. With the introduction of novel pharmacecuticals and newly appearing classes of drugs, BCC Research expects this market to reach $114 billion by 2018, a CAGR of 2.7% from 2013 to 2018.
Blood-Brain Barrier Technologies and Global Markets
The global market for blood-brain barrier (BBB) technology for therapeutics reached $21.8 million in 2013. This market is expected to grow from $38.7 million in 2014 to $471.5 million in 2019, a compound annual growth rate (CAGR) of 64.9% from 2014 through 2019.
Joint Reconstruction and Replacement: Materials, Technologies, an...
The global market for joint reconstruction and replacement was worth nearly $13.2 billion in 2013. This market is expected to increase to nearly $16.2 billion by 2018, registering a compound annual growth rate (CAGR) of 4.2% from 2013 through 2018.
Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Glo...
The global market for Multiple Sclerosis (MS) disease-modifying products reached $10.1 billion in 2012 and nearly $10.9 billion in 2013. This market is expected to grow to nearly $14.2 billion in 2018 with a compound annual growth rate (CAGR) of 5.4% over the five-year period from 2013 to 2018.
JAK and PI3K Signaling Pathway Markets
The global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012. This market is expected to grow to $464.5 million in 2013 and $2.2 billion in 2018 with a compound annual growth rate (CAGR) of 36.8% over the five-year period from 2013 to 2018.
Drugs for Treating Systemic Lupus Erythematosus: Global Markets
The global market for drugs to treat systemic lupus erythematosus (SLE) is expected to reach $950.2 million in 2013 and $2.6 billion in 2018, a compound annual growth rate (CAGR) of 22.4%.
Peripheral Vascular Surgical Products: Technologies and Global Ma...
The global market for peripheral vascular surgical devices reached $5.8 billion in 2012. This market is projected to grow from $6.2 billion in 2013 to $8.4 billion in 2018 with a compound annual growth rate (CAGR) of 6.3% for the five-year period, 2013 to 2018.
Histone Deacetylase Inhibitors: Emerging Markets
The global histone deacetylase inhibitor (HDI) market reached $153 million in 2011 and $223.2 million in 2012. This market is expected to be valued at $361.8 million in 2013 and $954.3 million by 2018, a compound annual growth rate (CAGR) of 21.4%.
Drugs for Treating Mental Disorders: Technologies and Global Mark...
The global market for drugs used in mental disorders was $70.1 billion in 2012 and $68.9 billion in 2013. This market is expected to rise at a compound annual growth rate (CAGR) of 2.3% from 2013 to 2018 and reach $77.1 billion by 2018.
Global Markets and Technologies for Advanced Drug Delivery System...
The global revenue for advanced drug delivery systems is estimated to be $181.9 billion in 2013. In 2018, revenues are estimated to reach $212.8 billion, demonstrating a compound annual growth rate (CAGR) of 3.2%.
Global Markets and Technologies for Advanced Drug Delivery System...
The global revenue for advanced drug delivery systems is estimated to be $181.9 billion in 2013. In 2018, revenues are estimated to reach nearly $212.8 billion, demonstrating a compound annual growth rate (CAGR) of 3.2%.
Global Markets and Technologies for Advanced Drug Delivery System...
The global revenue for advanced drug delivery systems is estimated to be $181.9 billion in 2013. In 2018, revenues are estimated to reach $212.8 billion, demonstrating a compound annual growth rate (CAGR) of 3.2%.
2013 Oncology Research Review
This BCC Research review provides highlights from oncology and other related market research reports published in 2013. It covers topics like uterine cancer, ovarian cancer, cervical cancer, prostrate cancer, and hematological disorders.
Global Markets and Technologies for Molecular Imaging Devices
The global market for molecular imaging devices was valued at $2 billion in 2012. This market is expected to reach $2.2 billion in 2013 and nearly $3 billion by 2018, with a compound annual growth rate (CAGR) of 6.2% for the period of 2013 to 2018.
Global Markets and Manufacturing Technologies for Protein Drugs -...
This report explores present and future strategies within the protein therapeutics market with a particular focus on peptide hormones and therapeutic enzymes. The report includes sales forecasts for year 2013 and 2018.
Global Markets and Manufacturing Technologies for Protein Drugs -...
This report explores present and future strategies within the protein therapeutics market with a particular focus on cytokines and monoclonal antibodies. The report includes sales forecasts for year 2013 and 2018.
Global Markets and Manufacturing Technologies for Protein Drugs -...
This report explores present and future strategies within the protein therapeutics market with a particular focus on blood factors, vaccines and peptide antibiotics. The report includes sales forecasts for year 2013 and 2018.
Therapies and Diagnostics for Uterine Cancer
The global market for uterine cancer treatments and diagnostics reached $17.4 billion in 2012. This market is expected to grow to nearly $17.8 billion in 2013 and then to nearly $21.6 billion in 2018, a compound annual growth rate (CAGR) of 3.9% over the five-year period from 2013 to 2018.
Medicines for Smoking Cessation: Global Markets
In 2012, the global smoking cessation medicine market had an estimated value of $2.11 billion. Estimated revenues in 2013 will be $2.12 billion. The market will observe growth after 2013 with a compound annual growth (CAGR) of 3.4% to reach $2.5 billion in 2018.
Global Markets for Contract Pharmaceutical Manufacturing, Researc...
This report provides an overview of the current and future global pharmaceutical contract packaging. The study includes estimates of sales figures for the five-year period from 2013 to 2018.
Global Markets for Emerging Insulin Drug and Delivery Technologie...
This study encompasses insulin drugs and delivery in pharmaceutical and biotechnology markets with a focus on insulin pumps. The study includes market projections through the end of 2013 and for a five-year period until 2018.
Global Markets for Contract Pharmaceutical Manufacturing, Researc...
This report provides an overview of the current and future global pharmaceutical contract manufacturing markets. The study includes estimates of sales figures for the five-year period from 2013 to 2018.
Global Markets for Contract Pharmaceutical Manufacturing, Researc...
This report provides an overview of the current and future global pharmaceutical contract research. The study includes estimates of sales figures for the five-year period from 2013 to 2018.
Drugs and Diagnostics for Hematological Disorders: Global Markets
This report provides an overview of the current and potential global market for hematological disorders and its treatments and testing technologies.
Cell Therapy Biomanufacturing: Global Markets
This report provides an overview of the global markets for cell therapy biomanufacturing.
Wearable Medical Devices: Technologies and Global Markets
This report provides an in-depth analysis of the medical devices industry and its competitive landscape.
Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets
This report provides a comprehensive analysis on technologies and applications of SNP genotyping, along with a critical perspective of the industry’s trends, future potential, and direction.
In Vitro Diagnostics (IVD) Quality Controls: Global Market
The report provides information on the latest developments in the quality control test, what are the latest technologies being used, and how the efforts are made by the key players introducing the products to markets.
Theranostics: Global Markets
This report will focus on theranotics, based products and types. Equipment as well as therapeutic agents. These reports include the approved drugs which are available on the market and research-based products.
Artificial Intelligence (AI) in Lifesciences Market
This report provides an overview of the market size of global artificial intelligence (AI) in the life sciences market.
Global Live Cell Imaging Market
This report focuses on the products and services offered in the live cell imaging market.
Global Single-cell Technologies Market
This report provides an overview of the global single-cell technologies market.
Gene Editing Therapeutics Market
This study encompasses an investigation of the gene editing therapeutics market. BCC Research analyzes gene editing therapeutics based on technology type, therapeutic area, and approach.
Global Multiomics Market
This report provides a comprehensive analysis of products, types, platforms, applications, and end-users of multiomics, along with a critical perspective of the industry's trends, future potential, and direction.
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
This report examines the current and forecasted market potential of radiopharmaceuticals and therapeutics. It offers a detailed analysis of the technological advancement, competitive environment, market background, drivers and restraints, and market growth trends.
Microelectronic Medical Implants: Products, Technologies & Opportunities
The goal of the report is to examine market opportunities for the microelectronic medical implant industry and the technologies that make possible the more advanced products that are rapidly coming into being.
Global Markets for Drug-Device Combinations
This report provides a detailed understanding of the global drug-device combination products market.
Global Automated and Closed Cell Therapy Market
This report provides a detailed market, technology, and industry analyses to help readers quantify and qualify the market for the closed and automated cell therapy market.
Medical Devices: Technologies and Global Markets
This report provides an in-depth analysis of the medical device technology market, including market estimations and trends. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail.
Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging
This report provides an overview of the global pharmaceutical and biopharmaceutical contract manufacturing, research and packaging market.
Drug Discovery Technologies
This report will provide detailed exposure to the drug discovery technologies, its current and future market potential and a detailed analysis of the competitive environment.
AI in Clinical and Molecular Diagnostics Market
This report explains critical trends in AI in clinical and molecular diagnostic industry. The report examines market determinants that serve as driving or inhibiting factors, offering valuable insights to stakeholders and potential entrants.
Life Science Tools and Reagents: Global Market Outlook
This report explores the current and future market potential for life science tools and reagents, its competitive environment, regulatory scenario, and market trends, including projections through 2029 and key players
Point of Care Diagnostics: Technologies and Global Markets
This report explores the current and future market potential for point of care diagnostics, its competitive environment, regulatory scenario, and market trends, including projections through 2029 and key players